Riskpilot← Back to searchSign inGet full accessMedinnova consulting AB
ABActiveOrg 5565849329Kaprifolvägen 2Business and other management consultancy activities · NACE 7020Est. 20000 employees
Revenue 2025
SEK 0
EBITDA margin
—
-24% vs 2024
Equity ratio
99.2%
Financial strength
Net profit 2025
SEK 438K
-1% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -12K | -24% |
| Net profit | SEK 438K | -1% |
| Total assets | SEK 1,3M | -1% |
| Equity | SEK 1,3M | -1% |
| Employees | 0 | — |
Legal name
Medinnova consulting AB
Org number
5565849329
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
22 februari 2000
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsult och utbildningsverksamhet inom företagshälsovård och sjukvård, framställande och utarbetandeav utbildningsmaterial, fastighetsförvaltning, värdepappershandel och därmed förenlig verksamhet.
Address
Kaprifolvägen 2
Email
info@medinnova.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −10 | −9 | −11 | −10 | −12 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −10 | −9 | −11 | −10 | −12 |
| Net financials | — | — | 85 | 450 | 450 |
| Profit before tax | −10 | −9 | 75 | 440 | 438 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −10 | −9 | 75 | 440 | 438 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 965 | 956 | 1 030 | 1 320 | 1 308 |
| Equity | 954 | 945 | 1 019 | 1 309 | 1 297 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 11 | 11 | 11 | 11 | 11 |
| Total debt | 11 | 11 | 11 | 11 | 11 |
EBITDA margin
-1238700.0%
This company
15.8%
Market median
-7839973% vs market
20212025
Equity ratio
99.2%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
33.7%
This company
18.4%
Market median
+83% vs market
20212025
Net profit margin
43761300.0%
This company
8.1%
Market median
+540262863% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medinnova consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Charlotta Sylvén Johansson | Deputy Board Member | 0 companies |
| Alf Thorbjörn Johansson | Board of Directors | 0 companies |